Summary Information:
Edgewise Therapeutics Inc. Common Stock
NASDAQ:EWTX


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Edgewise Therapeutics Inc. Common Stock
Exchange: NASDAQ
Symbol: EWTX
SEC CIK: 0001710072
Phone: 303-735-8373
3415 COLORADO AVE.
BOULDER CO 80303

CEO:
Price when page updated: 6.10 Date: 2023-11-30
Company Website:
edgewisetx.com

_Description: Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases.

IPO YEAR:
2021
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
387115809.00
Beta:

52 Week High:
40.49
52 Week Low:
13.19
52 Week Change:
-0.4656666666666667
Short Interest:

Short Date:

Shares Outstanding:
49295840
Dividend Rate:
0
Dividend Yield:
2.01%
ExDividend Date:

Latest EPS:

Latest EPS Date:
20 Oct 2022
Float:
0
return on Equity:
-21.10%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$1.265B
ttmEPS:
0
Revenue:
$1.991B
Gross Profit:

Cash:

Debt:

Institution Percent:
-
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.10%
Return on Assets:
-20.30%
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
2.12
Short Ratio:
13.38
PE Ratio:
0
Employees:
19
1Y Guesstimate
17.375:1.0:5




__The following are links to various summary and news pages for
__Edgewise Therapeutics Inc. Common Stock [ EWTX ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30